Biopharma Dive: Oramed’s oral insulin shines in mid-stage trials
Creating a safe, effective, tolerable oral insulin has become the holy grail of diabetes drug development, and Israel-based Oramed is one of the frontrunners in this race… http://www.biopharmadive.com/news/orameds-oral-insulin-shines-in-mid-stage-trials/419657/
Market Exclusive: Weekly Biotech Report Part II, Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP)
https://marketexclusive.com/weekly-biotech-report-part-ii-oramed-pharmaceuticals-inc-nasdaqormp/2016/05/
Reuters: Oramed Says Oral Insulin Succeeds in Midstage Type 2 Diabetes Trial
http://www.reuters.com/article/us-oramed-insulin-idUSKCN0Y91F2